| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/13/2001 | EP1105143A1 Human histone deacetylase gene hd4 |
| 06/13/2001 | EP1105141A2 Phosphatidylcholine as a medicament for the protection of mucosa |
| 06/13/2001 | EP1105133A1 Tricyclic compounds |
| 06/13/2001 | EP1105126A2 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 06/13/2001 | EP1105120A2 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION |
| 06/13/2001 | EP1105119A2 New use of taxoid derivatives |
| 06/13/2001 | EP1105100A1 Alginate capsules for use in the treatment of brain tumour |
| 06/13/2001 | EP0944571B1 Asiatic acid derivatives having modified a-ring |
| 06/13/2001 | EP0824527B1 Quinazoline derivatives |
| 06/13/2001 | EP0824526B1 Quinazoline derivative |
| 06/13/2001 | EP0820432B1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 06/13/2001 | EP0805858B1 Inhibition of neovascularization using vegf-specific oligonucleotides |
| 06/13/2001 | EP0789776B1 Nucleic acid transfer system |
| 06/13/2001 | CN1299414A Compound and method for therapy and diagnosis of lung cancer |
| 06/13/2001 | CN1299411A Hyperthermic inducible expression vectors for gene therapy and methods of use thereof |
| 06/13/2001 | CN1299410A CD 19XCD2 specific polypeptides and uses thereof |
| 06/13/2001 | CN1299369A Plasminogen-related gene B polypeptides |
| 06/13/2001 | CN1299366A 5-imino-13-doxy anthracycline derivatives, their uses, and processes for preparing them |
| 06/13/2001 | CN1299361A Hypnotic beta-carboline derivatives, process for their prepn. and their use as medicinal products |
| 06/13/2001 | CN1299358A Heterocyclic Topoisomerase poisons |
| 06/13/2001 | CN1299357A Indole derivatives useful A.O. for the treatment of osteoporosis |
| 06/13/2001 | CN1299350A Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of disease characterized by abnormal cell proliferation |
| 06/13/2001 | CN1299284A Arsenic sulfide compounds and derivatives thereof for the treatment cancer |
| 06/13/2001 | CN1299282A Vitronectin receptor antagonists |
| 06/13/2001 | CN1299280A Indoly-1-3-glyoxylic acid derivatives with antitumoral activity |
| 06/13/2001 | CN1299278A Inhibition of angiogenesis |
| 06/13/2001 | CN1299276A CYP2A enzymes and their use in therapeutic and diagnostic method |
| 06/13/2001 | CN1299249A Reagent for tumor therapy and/or imaging |
| 06/13/2001 | CN1298947A Virus with specigic reproduction in tumor well and effective expression of tumor angiogenesis inhibitor and its construction method |
| 06/13/2001 | CN1298883A Preparing process and application of recombined human interleukin-11 |
| 06/13/2001 | CN1298880A Cyanoribofuranoside compound and its preparing process |
| 06/13/2001 | CN1298871A 3-(fatty acid)-1,2 glceride disulfate and its preparing process and application |
| 06/13/2001 | CN1298869A Prourokinase and urokinase affinity ligand and its usage |
| 06/13/2001 | CN1298743A Low-poison efficient antineoplastic medicine and its preparing process |
| 06/13/2001 | CN1298733A Powder medicine 'Zhuyushengxin San' for treating stasis |
| 06/13/2001 | CN1298720A Oral liquid for curing leukemia and its preparing process |
| 06/13/2001 | CN1067075C Pyrrolo-gyrrolone used as neutrophil elastase inhibitor |
| 06/13/2001 | CN1067065C (-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate |
| 06/13/2001 | CN1066952C Medicine for treating various cancers |
| 06/12/2001 | US6245902 C-glycoside analogs and methods for their preparation and use |
| 06/12/2001 | US6245896 A polypeptide; diagnosis and therapy of endometriosis, antitumor/antiproliferative/anticarcinogenic agents; enhancing in situ fertilization |
| 06/12/2001 | US6245888 Proteins involved in the regulation of cell—cell adhesion and uses thereof |
| 06/12/2001 | US6245886 Peptides and peptidomimetics with structural similarity to human P53 that activate P53 function |
| 06/12/2001 | US6245885 Bax-mediated apoptosis modulating reagents and methods |
| 06/12/2001 | US6245811 Fatty acid esters as bioactive compounds |
| 06/12/2001 | US6245808 Oxy-vanadium (IV) complexes having spermicidal activity |
| 06/12/2001 | US6245805 Coadministering a taxane and a cyclosporin |
| 06/12/2001 | US6245790 Oxazole compounds useful as PGE2 agonists and antagonists |
| 06/12/2001 | US6245776 Drug mixture of immune response modifier, fatty acid, preservative and carbomer |
| 06/12/2001 | US6245760 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 06/12/2001 | US6245759 Tyrosine kinase inhibitors |
| 06/12/2001 | US6245750 Thymidine phosphoramide derivative; antiproliferative, anticarcinogenic agents; enzyme inhibitors; |
| 06/12/2001 | US6245748 Inhibition of an FGF-binding protein using ribozymes |
| 06/12/2001 | US6245742 Antitumor, anticarcinogenic and antimetastasis agents; viricides, psoriasis, antiinflammatory agents, antiallergens, psoriasis |
| 06/12/2001 | US6245562 Determining chromosomal breakpoint gene other than the immunoglobulin gene which is located in chromosome 14; complex between probe and the mrna; multiple myeloma |
| 06/12/2001 | US6245526 Mammalian nucleotide sequences which code polypeptides for the classification, diagnosis, treatment, and prevention of cell proliferative and lipid defects |
| 06/12/2001 | US6245523 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 06/12/2001 | US6245333 Isolated protein processed to peptides which form complexes with HLA molecules |
| 06/12/2001 | CA2203689C Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides |
| 06/12/2001 | CA2171453C Glutathione analogs and paralog panels comprising glutathione mimics |
| 06/12/2001 | CA2080917C New pharmacologically active catechol derivatives |
| 06/12/2001 | CA2072123C Inhibitors of purine nucleoside phosphorylase |
| 06/12/2001 | CA2046857C Morpholinyl derivatives of doxorubicin and process for their preparation |
| 06/11/2001 | WO2001044230A1 1-(aminophenyl)-2-pyrrolidones as integrin inhibitors |
| 06/11/2001 | CA2393310A1 1-(aminophenyl)-2-pyrrolidones as integrin inhibitors |
| 06/10/2001 | CA2327946A1 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/10/2001 | CA2327925A1 5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/07/2001 | WO2001040521A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 06/07/2001 | WO2001040499A2 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses |
| 06/07/2001 | WO2001040497A2 Method for obtaining nucleic acids from an environment sample |
| 06/07/2001 | WO2001040460A1 Screening method for compounds capable of modularing egr-1-regulated expression |
| 06/07/2001 | WO2001040457A1 Semaphorin receptor |
| 06/07/2001 | WO2001040456A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001040446A1 Pour-on formulations |
| 06/07/2001 | WO2001040442A1 Novel bacterial isolate and the preparation and use of its active metabolites |
| 06/07/2001 | WO2001040311A1 Chemokine slc-il2 fused protein and gene thereof |
| 06/07/2001 | WO2001040309A2 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 06/07/2001 | WO2001040303A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | WO2001040298A1 A new polypeptide - human protein kinase 9 and the polynucleotide encoding it |
| 06/07/2001 | WO2001040295A1 A new polypeptide - human zinc finger protein 48 and the polynucleotide encoding it |
| 06/07/2001 | WO2001040276A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 06/07/2001 | WO2001040271A2 Cancer associated antigens and uses therefor |
| 06/07/2001 | WO2001040251A1 Transforming growth factor alpha hiii |
| 06/07/2001 | WO2001040249A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001040240A2 Mono- and disaccharide derivatives |
| 06/07/2001 | WO2001040232A1 Chlorophyll and bacteriochlorophyll esters, and their preparation |
| 06/07/2001 | WO2001040231A1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 06/07/2001 | WO2001040218A1 Arylamine derivatives and their use as anti-telomerase agent |
| 06/07/2001 | WO2001040217A1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 06/07/2001 | WO2001040216A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | WO2001040215A1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 06/07/2001 | WO2001040214A1 Bryostatin analogues, synthetic methods and uses |
| 06/07/2001 | WO2001040204A1 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient |
| 06/07/2001 | WO2001040188A1 Curcumin analogues for treating cancer |
| 06/07/2001 | WO2001040181A1 Acryloyl peptidic derivatives, process for their preparation and their use as antitumor agents |
| 06/07/2001 | WO2001040142A2 P21 derived peptides capable of inhibiting cdk/cyclin complexes |
| 06/07/2001 | WO2001039806A1 Receptor binding conjugates |
| 06/07/2001 | WO2001039803A2 Interleukin-1 muteins useful as vaccine adjuvants |
| 06/07/2001 | WO2001039798A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 06/07/2001 | WO2001039788A2 Methods for targeting cells that express fibroblast growth receptor-3 or-2 |